Cost-effectiveness of prenatal food and micronutrient interventions on under-five mortality and stunting: Analysis of data from the MINIMat randomized trial, Bangladesh. by Svefors, Pernilla et al.
RESEARCH ARTICLE
Cost-effectiveness of prenatal food and
micronutrient interventions on under-five
mortality and stunting: Analysis of data from
the MINIMat randomized trial, Bangladesh
Pernilla Svefors1*, Katarina Ekholm Selling1, Rubina Shaheen1, Ashraful Islam Khan2,
Lars-Åke Persson1,3, Lars Lindholm4
1 International Maternal and Child Health, Department of Women’s and Children’s Health, Uppsala
University, Uppsala, Sweden, 2 International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b),
Dhaka, Bangladesh, 3 Department of Disease Control, London School of Hygiene and Tropical Medicine,
London, United Kingdom, 4 Department of Public Health and Clinical Medicine, UmeåUniversity, Umeå,
Sweden
* pernilla.svefors@kbh.uu.se
Abstract
Introduction
Nutrition interventions may have favourable as well as unfavourable effects. The Maternal
and Infant Nutrition Interventions in Matlab (MINIMat), with early prenatal food and micronu-
trient supplementation, reduced infant mortality and were reported to be very cost-effective.
However, the multiple micronutrients (MMS) supplement was associated with an increased
risk of stunted growth in infancy and early childhood. This unfavourable outcome was not
included in the previous cost-effectiveness analysis. The aim of this study is to evaluate
whether the MINIMat interventions remain cost-effective in view of both favourable
(decreased under-five-years mortality) and unfavourable (increased stunting) outcomes.
Method
Pregnant women in rural Bangladesh, where food insecurity still is prevalent, were randomized
to early (E) or usual (U) invitation to be given food supplementation and daily doses of 30 mg,
or 60 mg iron with 400 μg of folic acid, or MMS with 15 micronutrients including 30 mg iron and
400 μg of folic acid. E reduced stunting at 4.5 years compared with U, MMS increased stunting
at 4.5 years compared with Fe60, while the combination EMMS reduced infant mortality com-
pared with UFe60. The outcome measure used was disability adjusted life years (DALYs), a
measure of overall disease burden that combines years of life lost due to premature mortality
(under five-year mortality) and years lived with disability (stunting). Incremental cost effective-
ness ratios were calculated using cost data from already published studies.
Results
By incrementing UFe60 (standard practice) to EMMS, one DALY could be averted at a cost
of US$24.
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Conclusion
When both favourable and unfavourable outcomes were included in the analysis, early pre-
natal food and multiple micronutrient interventions remained highly cost effective and seem
to be meaningful from a public health perspective.
Introduction
Impaired antenatal and early life nutrition increases the risk of neonatal deaths and stunting.
According to global estimates, maternal and child undernutrition causes 3.1 million child
deaths annually [1]and contributes to 35% of disability adjusted life years (DALYs) in children
younger than 5 years[2]. The children who survive may suffer long-term consequences such
as cognitive impairment[3] and chronic diseases in adulthood[4]. Cost-effective child nutri-
tion interventions are available to improve survival and reduce the risk of stunting[5] (defined
as height-for-age less than -2 standard deviations of the WHO growth standards [6]. One
example is prenatal nutrition interventions that potentially benefit both the mother and the
offspring already at an early stage of development. Prenatal food supplementation, with mac-
ronutrients in the form of balanced protein-energy supplements, has resulted in improved foe-
tal growth and reduced perinatal mortality in low- and middle-income countries[7–9]. The
optimal timing of food supplementation and the best combination of micronutrients are not,
however, fully established. Routinely, supplementation of iron and folate is recommended for
pregnant women[10]. Yet, pregnant women in resource-poor settings are frequently deficient
in several micronutrients. Under this assumption supplements consisting of multiple micro-
nutrients (MMS) have been introduced.
Reports from studies aimed at studying the efficacy and safety of multiple micronutrient
(MMS) supplementation during pregnancy has varied; from encouraging results such as
reduced prevalence of low birth weight[11,12] and small-for-gestational-age (SGA) births[13],
to suggested increased risks of perinatal and neonatal mortality[14]. No reduction in child
mortality or subsequent linear growth failure have been reported in meta-analyses[15]. Most
of the published MMS trials have been implemented in resource-poor settings where the popu-
lation face both macro- and micronutrient deficiencies. In spite of this, MMS has not been
given in combination with food supplementation.
In the randomized MINIMat trial (Maternal and Infant Nutrition Interventions, Matlab,
isrctn.org identifier ISRCTN16581394), prenatal MMS supplementation was combined with
early or usual timing of food supplementation. Previous results have demonstrated substantial
reduction in under-five year mortality with MMS combined with early (E) invitation to prena-
tal food supplementation (i.e. EMMS) compared with the standard 60 mg iron, 400 gm folic
acid and invitation to food supplementation at the usual time in pregnancy (UFe60F)[16].
Conversely, infant mortality did not differ across the two timings of food supplementations or
the three micronutrient treatment groups. In addition, MMS supplementation was related to
more stunting in comparison with Fe60F, while the early invitation to food supplementation
compared with the usual timing of the start of supplementation was associated with reduced
frequency of stunting before the age of five years[17]. The potential negative effect by prenatal
MMS on child linear growth was also supported by lower insulin-like growth factor 1 at 4.5
years in children whose mothers had been allocated to this treatment [18]. This combination
of favourable and unfavourable effects illustrates that nutrition interventions may influence
multiple outcomes that may be positive as well as negative from a public health perspective. As
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cost-effectiveness analyses often form part of the basis for decisions on large scale implementa-
tion, it is important to include not only primary outcomes but also nutrition intervention’s
potential long-term effects.
The MINIMat interventions have been reported to be cost-effective in respect of the pri-
mary outcome of reduced infant mortality[19]. However, the potential long-term adverse
effects of MMS due to increased stunting were not included in the analysis. The aim of this
study is to evaluate the cost-effectiveness of the MINIMat interventions of early food and
MMS supplementation compared with usual timing of food and routine iron and folate sup-
plementation, taking into account both premature death (under five-year mortality) and long-
term disability (stunting) in terms of cost per disability adjusted life years (DALYs) averted.
Methods
Participants, study design and setting
The data originate from the MINIMat trial (Maternal and Infant Nutrition Interventions in
Matlab), a factorial randomized trial carried out in Matlab, Bangladesh, a rural sub-district 57
km south-east of the capital Dhaka where food insecurity is still prevalent. At the time when
the trial was implemented, the under-five mortality rate in Bangladesh was 74 per 1000 live
births [20] and the prevalence of under-five stunting 50% [21]. Pregnant women were
recruited to participate in the MINIMat trial from November 2001 to October 2003 and ran-
domized to two daily food supplementation groups, early invitation (E, at about 9 weeks of
pregnancy), or usual timing (U, at about 20 weeks of pregnancy) with 600 kcal six days per
week. Further, there were three separate micronutrient groups given from 14 weeks of gesta-
tion: 60 mg iron and 400 μg folic acid (routine); multiple micronutrients (MMS) with 15
micronutrients, including 30 mg iron and 400 μg folic acid; or 30 mg iron and 400 μg folic acid
to control for the lower amount of iron in the MMS supplement. This resulted in six interven-
tion groups, EFe60F (n = 738), EMMS (n = 740), EFe30F (n = 739), UFe60F (n = 738), UMMS
(n = 740) and UFe30F (n = 741). In total, 4436 pregnant women participated, giving birth to
3625 live born children from April 2002 to June 2004. Children of mothers participating in the
MINIMat trial were followed from birth to 5 years in regards to mortality and to 4.5 years in
regards to stunting. The 4.5-year follow-up took place from April 2007 to February 2009.
Ethics
Written informed consent was obtained from all parents of participating children (separately
for the original trial and the two follow-ups). The Ethical Review Committee at the Interna-
tional Centre for Diarrhoeal Disease Research, Bangladesh and the Regional Ethical Review
Board at Uppsala University, Sweden approved the study (separately for the original trial and
the two follow-ups).
Cost data
Cost data were retrieved from a recent study by Shaheen et al.[19], which evaluated the cost
effectiveness of the MINIMat interventions in regards to reduced infant mortality. Most cost
data in the study by Shaheen were available from Khan and Ahmed[22] whereby an “ingredi-
ent” or “bottom up” approached was used (enumerators identified and valued each resource
required for, and produced by, the nutrition intervention delivery) while data on cost of
micronutrients and some staff costs were obtained from the MINIMat project administration.
Shaheen et al reported costs for three different delivering modes: 1) NGO; and 2) government-
run community nutrition centres (CNCs); as well as a 3) hypothetical highest-cost scenario
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combining the highest cost for each item presented for NGO-run and government-run CNCs.
In this study, we present costs for the highest cost scenario only. The direct costs for the inter-
vention included micronutrient and food supplements, staff, training and administration, cap-
ital, community volunteer time, and recurrent activities. Khan and Ahmed [22] annualized all
capital costs at a 5% discount rate, further discounting was not done but all costs were adjusted
to the price levels for 2015 using the consumer price index [23]. The indirect costs comprised
the cost of the participants’ time and estimated as cost of a laborer when labor cost was the
lowest. All the cost items except the micronutrient capsules were summarized, representing
the cost per pregnant woman for food. The total cost for supplementing one woman was
finally calculated by taking the cost per pregnant woman for food multiplied by the adherence
to food, plus the cost for micronutrients capsules, also multiplied by the adherence to micro-
nutrients[24].
Effects
The effect measure is presented as disability adjusted life years (DALYs) averted. DALYs are a
measure of overall disease burden that combines years of life lost due to premature mortality
(YLLs) and the time spent in an impaired health state, measured as years lived with disability
(YLDs). One DALY lost is to be interpreted as one lost year of healthy life. Consequently, one
DALY averted is equivalent to the gain of one year of healthy life. Calculating the cost per
DALY averted facilitates comparison between different health interventions as well as enables
the evaluation of an intervention’s effects on both premature death and long-term disability.
The term disability here refers to loss of health due to stunting.
DALYs are typically attributed to a specific disease, health state or age group. As the MINI-
Mat interventions had an effect on both under-five deaths and stunting, DALYs were equal to
YLL due to all-cause premature mortality plus YLD due to stunting. DALYs were calculated
based on strictly empirical data from the trial for up to five years (DALY5s) and from a lifetime
perspective based on secondary data (DALYs). To calculate YLL for DALY5s, we used the exact
mortality age of the children who died and subtracted the age at death from 5 years. YLDs were
calculated as the sum of months the children had been stunted from birth to 5 years (i.e., they
had a height-for-age Z-score below -2 from the WHO reference median) times a disability
weight[25]. The children’s length/height were measured 18 times; at birth, every month up to
one year, and every three months up to 24 months and then again at 4.5 years. Height-for-age
z-scores were calculated by the program WHOAnthro using the WHO growth references[26].
Height-for-age data were linearly interpolated if height measurements were missing in some
age intervals between birth and 2 years of age. For example, if the 5-month height measurement
was missing for a study participant, the height-for-age z-score was imputed by linear interpola-
tion of the 4- and 6-month height-for age z-scores of that individual. If two or more subsequent
values were missing, the values were imputed from the weighted average of the previous and fol-
lowing z-scores. No child had more than 6 subsequent imputed values from birth to 2 years.
From 2 to 4.5 years, the height-for-age z-scores were linearly interpolated for every 3-month
period to attain a more accurate estimation of months lived with stunting. Children who were
stunted at the assessment at 4.5 years of age were assumed to also be stunted at 5 years.
To calculate DALYs from a lifetime perspective, the number of YLL and YLDs were created
using the following assumptions. As most child deaths occurred in early infancy, the life expec-
tancy at birth (LE) was used for YLLs. The remaining life expectancy (RLE) at 5 years was used
for YLDs. LE and RLE at 5 years in the Matlab area were based on the demographic surveil-
lance data from the year 2003 and 2008, estimated to 69.3 and 69.7 for girls and 67.8 and 66.9
years for boys[27,28]. YLLs and YLDs were discounted with a discount rate of 3%. The average
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proportion of recovery and incidence of stunting in each intervention group between 4.5 and
10 years were used to calculate YLDs from 5 to 10 years[29]. Stunted children were assumed to
be equally affected by stunting throughout infancy, childhood and adulthood. It was assumed
that children who were stunted at 4.5 years remained stunted at 5 years and that children who
were stunted at 10 years remained so throughout life[30]. Two different disability weights
were used. The disability weight attributed to stunting by the global burden of disease study
was 0.002[25]. However, to avoid underestimating the potential long-term consequences of
cognitive impairment, we chose to include the higher disability weight of 0.024 for develop-
ment disability due to malnutrition[25]. Finally, the mean of the YLLs and YLDs in each inter-
vention group were summed up to attain the final DALY estimate. The assumptions used to
calculate DALYs and DALY5s are summarised in Box 1.
Analyses
To obtain incremental cost effectiveness ratios (ICERs) for DALYs averted, we calculated the
costs for supplementing 1 pregnant woman following the regimes in each intervention arm.
Box 1. Key assumptions used to calculate DALY5s
• Children were assumed to grow linearly. Height data were linearly interpolated if
height measurements were missing in the age interval between birth and 2 years of
age. From 2 to 4.5 years, height-for-age z-scores were imputed every 3 months.
• Duration of disability: Duration of stunting, for up to 5 years, was obtained from
observed data. Children who were stunted at 4.5 years were assumed to be stunted at 5
years.
• Disability weights used: 0.002 (stunting) and 0.024 (developmental delay). Stunted
children were assumed to be equally affected by the disability caused by stunting
throughout infancy and childhood.
• Discount rate: No discounting.
Key assumptions used to calculate DALYs
• Duration of disability: Duration of stunting, for up to 5 years, was obtained from
observed data. From 5 to 10 years, the average proportion of recovery and incidence of
stunting in each intervention group between 4.5 and 10 were used. Children who were
stunted at 4.5 years were assumed to be stunted at 5 years, and children who were
stunted at 10 years were assumed to continue being stunted throughout life.
• Disability weights used: 0.002 (stunting) and 0.024 (developmental delay). Stunted
children were assumed to be equally affected by the disability caused by stunting
throughout infancy, childhood and adulthood.
• Discount rate: 3%.
Life expectancy: LE at birth for YLL, and RLE at 5 years for YLD. Discounted LE and
RLE for girls; 28.66 and 29.03 years. Discounted LE and RLE for boys; 28.16 and 28.84
Cost-effectiveness of prenatal food and micronutrient interventions on under-five mortality and stunting
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These were then sorted according to ascending costs and dominating alternatives were
excluded (i.e., alternatives with both a higher cost and a higher DALY estimate). This proce-
dure resulted in three remaining intervention arms. Lastly, we calculated the increment in
costs and DALYs across these three arms and divided the cost differences by the differences
between DALYs, which gave the ICERs.
Results
There were 4,436 women enrolled into the MINIMat trial, of whom 845 were lost to follow-up
before delivery, mainly due to fetal loss, outmigration or because they withdrew their consent.
Of the 3,625 live born children 2,851 had anthropometry at 4.5 years (Fig 1). Background char-
acteristics of the mothers and children of the MINIMat trial is presented in Table 1. The moth-
ers had an average of 5.2 years (SD 4.1) of education and 40% of the mothers belonged to the
lowest socioeconomic category. The mean maternal height was 149.8 cm (SD 5.3), mean
maternal weight was 45.3 kg (SD 6.8), and one third of the of the mothers were underweight,
with a body mass index of less than 18.5 at enrolment. The average birth length and weight of
the children were 47.7 cm (SD 2.2) and 2,694 grams (SD 410) respectively. More than half of
the children (59%) were born small for gestational age (SGA). The baseline characteristics
were similar across the six intervention groups.
Costs
Adherence levels and costs for a hypothetical highest-cost delivery scenario are presented in
Table 2. Using these figures, supplementing 1 pregnant woman would cost US$82.12, US
Fig 1. Flow diagram of women and infants participating in the MINIMat trial. E = Early invitation food supplementation, U = Usual invitation food
supplementation; 30F = 30 mg iron and 400 μg of folic acid; 60F = 60 mg iron and 400 μg of folic acid; MMS = multiple micronutrients, 15 micronutrients
including 30 mg iron and 400 μg of folic acid.
https://doi.org/10.1371/journal.pone.0191260.g001
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$79.46, US$86.19, US$55.34, US$54.42, and US$56.73 for E30F, E60f, EMMS, U30F, U60F
and UMMS, respectively.
YLLs, YLSs, YLDs and DALYs
Years lost to premature mortality (YLL), years lived with stunting (YLS), years lived with dis-
ability (YLD) and disability adjusted life years (DALYs) lost, for up to 5 years and calculated
from a lifetime perspective, are presented in Tables 3 and 4. The average number of years lost
to premature mortality was lowest in the EMMS group and highest in the UMMS group, both
for up to five years and from a lifetime perspective (0.080, 0.27 YLLs up to 5 years and 0.62,
2.09 YLLs for the lifetime). The UMMS group also had the highest estimated number of years
lived with stunting in both scenarios (1.68, 12.92 YLS). The least number of years were lived
with stunting in the E60Fe group, for up to 5 years, and in the U30Fe group over a lifetime.
The DALY5s and DALYs lost were lowest in the EMMS group (0.08 and 0.64) and highest in
the UMMS group (0.28 and 2.12), irrespective of disability weight used.
Incremental cost-effectiveness ratios
Incremental costs, incremental DALYs and incremental cost-effectiveness ratios (ICER) are
presented in Table 5 for up to 5 years, and in Table 6 from a lifetime perspective. After exclud-
ing the alternatives that had both a higher cost and a higher DALY estimate than the standard
Table 1. Baseline characteristics of mothers at 8 weeks of gestation and children at birth participating in the
MINIMat trial, Bangladesh.
CHARACTERISTICS n %
Mothers
Age
<20 916/3267 16.0
20–29 1862/3267 57.0
30 882/3267 27.0
BMI at 8 weeks
<18.5 916/3255 28.1
18.5 2339/3255 71.9
Education
No Education 1016/3267 31.1
Can read and write 2251/3267 68.9
SES category
Low 1329/3267 40.7
Middle 651/3267 19.9
High 1287/3267 39.4
Children
Sex
Girl 1605/3267 49.1
SGA 1 1928/3267 59.0
LBW2 997/3267 30.5
Preterm 3 258/3267 7.9
1Small for Gestational Age (Birth weight below reference for gestational week at birth (30)
2Low Birth Weight (<2500 g)
3Born before 37 weeks of gestation
https://doi.org/10.1371/journal.pone.0191260.t001
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alternative of U60Fe, (i.e., the dominated alternatives), we ended up with three remaining
intervention arms, EMMS, U30Fe and U60Fe, for both scenarios. A total of 0.1 DALY5s and
0.7 DALYs per child were averted by switching to U30Fe, and 0.2 DALY5s and 1.3 DALYs per
child were averted by switching to EMMS. The ICER for one extra DALY5 averted by switch-
ing from UFe60 to UFe30 was US$11.5, and from UFe60 to EMMS, US$186.9. The corre-
sponding figures for one DALY averted were US$1.4 and US$24.4, respectively. When using
the higher disability weight of 0.024, the ICER increased by US$2 to US$26.3 per DALY
averted (S1 Table).
Discussion
Main findings and consequences for public health policy
When favourable (decreased under-five year mortality) and unfavourable (increased stunting),
outcomes of the MINIMat trial were included in the analysis the implementation of EMMS
supplementation, when compared to U60Fe, remained highly cost-effective. The incremental
cost effectiveness ratio per 5 years and lifetime DALY averted of US$187 and US$24 both fall
well below Bangladesh’s per-capita gross national income (US$1190 in 2015) and compare
favourably to corresponding interventions evaluated elsewhere in South Asia[31–33]. In a
community-based newborn care intervention in Bangladesh, one DALY could be averted at a
Table 2. Adherence to and cost of food supplements and micronutrient capsules and cost for supplementing one woman.
Adherence to food packets Adherence to micronutrient capsules Cost for supplementing one woman1,2,3
EFe30 91 109 82.12
EFe60 88 113 79.47
EMMS 94 107 86.19
UFe30 61 117 55.34
UFe60 60 113 54.42
UMMS 61 110 56.73
Adherence to and cost of food supplements and micronutrient capsules and for supplementing one woman in the MINIMat trial, Bangladesh.
1 US dollars adjusted to price levels 2015 using consumer price index (World bank)
2 Cost per pregnant woman for food 0.895, cost for micronutrient capsule MMS 0.020, iron-folic acid 30/60 0.0065
3 Cost for supplementing one woman (cost for food packets  adherence to food packets) + (cost for micronutrient capsule  adherence to micronutrient capsules)
https://doi.org/10.1371/journal.pone.0191260.t002
Table 3. YLL, YLS, YLD and DALY estimates for up to 5 years within the MINIMat study.
YLL 1 YLS2 YLD3 DALY54
Mean (sd) Mean (sd) Mean (sd)
0.002
Mean (sd) 0.024 Mean (sd)
0.002
Mean (sd) 0.024
E30Fe 0.2272(1.00) 1.54 (1.82) 0.0031 (0.0036) 0.0369(0.04) 0.2303(1.00) 0.2641(0.99)
E60Fe 0.2216(1.00) 1.34(1.73) 0.0027 (0.0035) 0.0322(0.04) 0.2243(1.00) 0.2539(0.99)
EMMS 0.0800(0.61) 1.56(1.83) 0.0031 (0.0037) 0.0375(0.04) 0.0831(0.61) 0.1174(0.61)
U30Fe 0.1690(0.87) 1.59(1.86) 0.0032 (0.0037) 0.0383(0.05) 0.1720(0.87) 0.2069(0.86)
U60Fe 0.2510(1.05) 1.59(1.90) 0.0033 (0.0038) 0.0383(0.05) 0.2542(1.05) 0.2893(1.04)
UMMS 0.2737(1.10) 1.68(1.93) 0.0034 (0.0039) 0.0404(0.05) 0.2770(1.10) 0.3140(1.09)
1 Years of life lost due to premature mortality for up to 5 years
2 Years lived with stunting, up to 5 years
3 Years lived with disability, years lived with stunting multiplied by the disability weight of 0.002 and 0.024
4 YLL+YLD for up to five years
https://doi.org/10.1371/journal.pone.0191260.t003
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cost of US$103[34], and, in Nepal, a participatory women’s group intervention reported an
ICER of US$211[32] per life year saved, which is much higher than our estimates.
The main aim of this study was to evaluate the cost of switching from the routine prenatal
supplementation of 60 mg iron and folate plus the usual timing (week 20) of daily food supple-
ments (U60Fe) to the potentially superior multiple micronutrients plus an early invitation
(week 9) to food supplementation (EMMS) including both favourable and unfavourable out-
comes, but all the intervention arms were included in the analysis. It turned out that switching
from U60Fe to U30Fe had the lowest ICER, at US$1.4 per DALY averted. As the cost for the
two interventions were similar, the ICER for switching from U60Fe to U30Fe was mainly
driven by the slightly lower DALYs in the U30Fe group due to primarily lower YLL but also
lower YLD estimates. The fact that U30Fe would have a lower YLL estimate was somewhat
expected as the U30Fe group had a lower mortality hazard ratio in the survival analysis by
Persson et al. [16] than U60Fe (0.67), although not statistically significant (CI 0.69–1.7)[16].
The WHO recommendations for iron supplementation during pregnancy is 30–60 mg per
day, the higher dose recommended in settings where anaemia in pregnant women is
Table 4. YLL, YLS, YLD and DALY estimates within the MINIMat study.
YLL1 YLS2 YLD3 DALY4
Mean (sd) Mean Mean
0.002
Mean
0.024
Mean
0.002
Mean
0.024
E30Fe 1.7162(7.37) 11.7417 0.0235 0.2818 1.7397 1.9980
E60Fe 1.7054(7.34) 10.1577 0.0203 0.2438 1.7257 1.9492
EMMS 0.6177(4.49) 11.4962 0.0230 0.2759 0.6406 0.8936
U30Fe 1.2825(6.42) 9.7237 0.0194 0.2334 1.3019 1.5159
U60Fe 1.9173(7.77) 11.8206 0.0236 0.2837 1.9409 2.2010
UMMS 2.0938(8.09) 12.9199 0.02584 0.3101 2.1196 2.4039
1 Years of life lost due to premature mortality when LE at birth discounted at 3%, present value 29.04, 28.84 for women and men.
2 Years lived with stunting when RLE at five years discounted at 3%, present value 28.66, 28.16 for women and men.
3 Years lived with disability, years lived with stunting multiplied by the disability weight of 0.002 and 0.024, respectively
4 YLL+YLD
https://doi.org/10.1371/journal.pone.0191260.t004
Table 5. Incremental cost-effectiveness ratios for cost per DALY5s averted.
Cost/woman DALYs/child1 Comparison Incremental cost Incremental DALY5s ICER2
U60fe 54.4157 0.2542
U30Fe 55.3364 0.1720
UMMS 56.7306 0.2770
E60Fe 79.4645 0.2243
E30Fe 82.1221 0.2303
EMMS 86.1935 0.0831
Incremental cost-effectiveness ratios after excluding dominated alternatives
U60fe 54.4157 0.2542 U60fe-U30Fe 0.92 0.08 11.5
U30Fe 55.3364 0.1720 U30Fe-EMMS 30.86 0.09 342.9
EMMS 86.1935 0.0831 60Fe-EMMS 31.78 0.17 186.9
Incremental cost-effectiveness ratios for cost per DALY averted for the different MINIMat prenatal food and micronutrient supplementation arms.
1 Disability weight 0.002
2 Incremental cost/Incremental DALYs
https://doi.org/10.1371/journal.pone.0191260.t005
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widespread, such as rural Bangladesh, where the prevalence of anaemia in pregnant women is
estimated to be 49.6%[35]. However, the prevalence of iron deficiency in Bangladesh and in
the MINIMat population is reportedly low due to high levels of iron in the groundwater
[36,37], suggesting that other micronutrient deficiencies or infections might be important
causes. Further, superfluous supplementation of iron could contribute to an excess iron load
with potential health hazards[38,39].
Although switching from U60fe to U30Fe had the lowest ICER, EMMS had the lowest
DALY estimate. Switching from U60Fe to EMMS would avert twice as many DALYs as switch-
ing to U30Fe. As the ICER of US$24 can be considered highly cost-effective and affordable in
a low-resource setting, switching from U60Fe to EMMS is viable both from a public health
and economic perspective. In addition, as mentioned above, when modelled, the estimates
that generated the lower YLLs and YLDs in the U30Fe intervention group were not statistical
significant[16].
The lower DALYs in the EMMS group was driven primarily by the lower YLLs as the differ-
ence in YLD between U60Fe and EMMS was minor. Meta-analyses of prenatal multiple micro-
nutrient supplementation trials have reported limited increases in birth weight in comparison
with iron-folic acid supplementation alone[11,12], and some reduction in the prevalence of
small-for-gestational-age births[13], but no reduction in the risk of child mortality or subse-
quent linear growth failure[15]. A recent Cochrane review of prenatal MMS supplementation
found high-quality evidence for a small reduction of the occurrence of stillbirth outcomes but
no effect on perinatal or neonatal mortality[40]. The newly updated WHO guidelines on ante-
natal care do not recommend multiple micronutrients for pregnant women[41].
What makes the MINIMat interventions different to the trials included in the above-men-
tioned studies is that the multiple micronutrient supplementation was combined with food
supplementation early in pregnancy and the reduction in mortality was only seen as a com-
bined effect of early food supplementation and MMS. MMS given without food supplementa-
tion in early pregnancy (UMMS) had the highest DALY estimates as a result of both the
highest number of YLLs and YLDs. Further, in a recently published study the MINIMat trial
children allocated to the multiple micronutrient supplementation displayed an unfavourable
metabolic profile at 4,5 years with lower levels of IGF and HDL[18]. These results indicate
Table 6. Incremental cost-effectiveness ratios for cost per DALY averted.
Cost/woman DALYs /child1 Comparison Incremental cost Incremental DALYs ICER2
U60fe 54.4157 1.9409
U30Fe 55.3364 1.3019
UMMS 56.7306 2.1196
E60Fe 79.4645 1.7257
E30Fe 82.1221 1.7397
EMMS 86.1935 0.6406
Incremental cost-effectiveness ratios after excluding dominated alternatives
U60fe 54.4157 1.9409 60fe-U30Fe 0.92 0.64 1.4
U30Fe 55.3364 1.3019 30Fe-EMMS 30.86 0.66 46.8
EMMS 86.1935 0.6406 60Fe-EMMS 31.78 1.30 24.4
Incremental cost-effectiveness ratios for cost per DALY averted for the different MINIMat prenatal food and micronutrient supplementation arms.
1 Disability weight 0.002
2 Incremental cost/Incremental DALYs
https://doi.org/10.1371/journal.pone.0191260.t006
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positive outcomes of providing MMS only when it is combined with increased macronutrient
intake that is initiated in early pregnancy.
Generalisability
The MINIMat trial was a community-based trial, conducted in an area with a well-established
health and demographic surveillance system and an excellent research infrastructure that ful-
fils the prerequisites for obtaining high-quality data. The randomised design minimised the
risk of potential confounding and double masking of the micronutrient intervention reduced
the risk of reporting or observation bias.
In the area where the trial was conducted, women are still frequently exposed to food inse-
curity and enter pregnancy deficient in several micronutrients. This makes the ICERs esti-
mates valid to other rural areas in Bangladesh and to similar settings in other countries that
struggle with problems of widespread maternal malnutrition. The cost data retrieved from the
study by Shaheen et al. were collected within the same time-frame and in a situation similar to
that of the MINIMat trial, which is why we believe they reasonably represent costs associated
with the MINIMat interventions. Shaheen et al. presented three different delivery modes,
resulting in three cost scenarios, NGO-run clinics, governmental-run clinics and a highest-
cost delivery mode where the highest costs for different items from NGO- and government-
run clinics were combined. As we used the highest cost scenario in our analysis, our generated
ICERs might be somewhat overestimated.
Methodological considerations
Most nutrition interventions have multiple objectives and outcomes. In this study, we included
two outcomes; premature mortality, and disability caused by stunting, aware that this do not
represent all potential benefits or harms of the intervention[42].
When evaluating the cost-effectiveness of multiple outcomes, the issue of assigning values
to the different outcomes becomes essential. The disability weight attributed to stunting by the
global burden of disease study, 0.002, is small. In order to avoid underestimating the long-
term effects of stunting, we chose to include the larger disability weight attributed to develop-
ment delay due to malnutrition, although not all stunted children will suffer from cognitive
impairment. When using the higher disability weight, the ICER only increased from US$24 to
US$26 as differences in YLS between the intervention groups were small. The differences in
YLS and YLL between the intervention group with the lowest and highest estimate were 3.2
YLS (UMMS-U30Fe) and 1.47 YLL (UMMS-EMMS) respectively. Thus, for the differences in
YLS to change the ranking of the highest and lowest DALY estimate, the disability weight
would have to be at least as high as 0.4 (1.47/3.2), equal to multiple sclerosis or bipolar disor-
der[25]. Further, the disability weights, and thus the cost-effectiveness analysis, does not con-
sider stunting’s additional health and economic consequences for the individual and
community, such as impaired pregnancy outcomes for women[43], higher risk of non-com-
municable disease[44], fewer years of schooling [45]and lower earnings[3]. However, the con-
clusion that switching from Ufe60 to EMMS is highly cost-effective would not change if you
increase the impact of stunting, as U60Fe had higher YLS estimates than EMMS. The eco-
nomic impacts of stunting might better be valued in monetary units and by using cost-benefit
analysis.
Another key assumption associated with the impact of stunting was that all children who
were stunted at 10 years continued to be stunted throughout life, based on the fact that adult
stature is strongly associated with pre-pubertal height [30]. This assumption applies equally for
Cost-effectiveness of prenatal food and micronutrient interventions on under-five mortality and stunting
PLOS ONE | https://doi.org/10.1371/journal.pone.0191260 February 15, 2018 11 / 15
all intervention groups, and hence, does not significantly affect the difference in DALYs or the
ICERs.
The estimate of US$187 per DALY averted for up to 5 years was based on strictly observed
data from the trial and was not subject to any assumptions except the disability weight for
stunting. However, by not considering the number of life years lost to premature mortality
and disability beyond the age of 5 years, the intervention is at a disadvantage when compared
with alternatives, which are usually analysed from a lifetime perspective.
Conclusions
Including stunting as an outcome did not alter the conclusion that the MINIMat interventions
of early prenatal food and MMS supplementation were highly cost-effective in a population
where maternal undernutrition is still common. The ICER of US$24 for switching from invita-
tion to food supplementation at the usual time in pregnancy and iron-folic acid supplementa-
tion to an early initiation of food supplementation combined with MMS can be considered
affordable in a low-resource setting and viable from both a public health and economic per-
spective. These results can hopefully inspire others to consider multiple outcomes of nutri-
tional interventions in economic evaluations and help to support decision-makers in the
prioritizing of financing for nutrition interventions targeting pregnant women’s health.
Supporting information
S1 Table. Incremental cost-effectiveness ratios (ICERs) for cost per DALY averted for the
different MINIMat prenatal food and micronutrient supplementation arms, disability
weight 0.024.
(DOCX)
S1 Dataset. Anonymized data set.
(SAV)
Acknowledgments
We thank the participants and their families in Matlab for their continuing involvement in the
MINIMat trial, and the field-team members and data management staff for their excellent
work.
Author Contributions
Conceptualization: Pernilla Svefors, Katarina Ekholm Selling, Lars-Åke Persson, Lars
Lindholm.
Data curation: Pernilla Svefors, Ashraful Islam Khan, Lars-Åke Persson.
Formal analysis: Pernilla Svefors, Rubina Shaheen.
Funding acquisition: Lars-Åke Persson.
Supervision: Lars Lindholm.
Writing – original draft: Pernilla Svefors.
Writing – review & editing: Katarina Ekholm Selling, Rubina Shaheen, Ashraful Islam Khan,
Lars-Åke Persson, Lars Lindholm.
Cost-effectiveness of prenatal food and micronutrient interventions on under-five mortality and stunting
PLOS ONE | https://doi.org/10.1371/journal.pone.0191260 February 15, 2018 12 / 15
References
1. Black RE, Victora CG, Walker SP, Bhutta ZA, Christian P, de Onis M, et al. Maternal and child undernu-
trition and overweight in low-income and middle-income countries. Lancet. 2013; 382:427–51. https://
doi.org/10.1016/S0140-6736(13)60937-X PMID: 23746772
2. Black RE, Allen LH, Bhutta ZA, Caulfield LE, de Onis M, Ezzati M, et al. Maternal and child undernutri-
tion: global and regional exposures and health consequences. Lancet. 2008; 371:243–60. https://doi.
org/10.1016/S0140-6736(07)61690-0 PMID: 18207566
3. Grantham-McGregor S, Cheung YB, Cueto S, Glewwe P, Richter L, Strupp B. Developmental potential
in the first 5 years for children in developing countries. Lancet. 2007; 369:60–70. https://doi.org/10.
1016/S0140-6736(07)60032-4 PMID: 17208643
4. Prentice AM, Moore SE. Early programming of adult diseases in resource poor countries. Arch Dis
Child.2005; 90:429–32. https://doi.org/10.1136/adc.2004.059030 PMID: 15781942
5. Bhutta ZA, Ahmed T, Black RE, Cousens S, Dewey K, Giugliani E, et al. What works? Interventions for
maternal and child undernutrition and survival. Lancet. 2008; 371:417–40. https://doi.org/10.1016/
S0140-6736(07)61693-6 PMID: 18206226
6. de Onis M, World Health Organization. WHO child growth standards: length/height-for-age, weight-for-
age, weight-for-length, weight-for-height and body mass index-for-age: methods and development.
Geneva: World Health Organization; 2006.
7. Kramer MS, Kakuma R. Energy and protein intake in pregnancy. Cochrane Database Syst Rev. 2003;
4:CD000032. https://doi.org/10.1002/14651858.CD000032
8. Ceesay SM, Prentice AM, Cole TJ, Foord F, Poskitt EME, Weaver LT, Whitehead RG. Effects on birth
weight and perinatal mortality of maternal dietary supplements in rural Gambia: 5 year randomised con-
trolled trial. BMJ. 1997; 315:786–90. PMID: 9345173
9. Imdad A, Bhutta ZA. Effect of balanced protein energy supplementation during pregnancy on birth out-
comes. BMC Public Health.2011; 11:S17. https://doi.org/10.1186/1471-2458-11-S3-S17 PMID:
21501434
10. World Health Organization. WHO Guideline: Daily iron and folic acid supplementation in pregnant
women. Geneva: World Health Organization; 2012.
11. Fall CHD, Fisher DJ, Osmond C, Margetts BM. Multiple Micronutrient Supplementation during Preg-
nancy in Low-Income Countries: A Meta-Analysis of Effects on Birth Size and Length of Gestation.
Food Nutr Bull. 2009; 30:S533–46. https://doi.org/10.1177/15648265090304S408 PMID: 20120795
12. Margetts BM, Fall CHD, Ronsmans C, Allen LH, Fisher DJ, Maternal Micronutrient Supplementation
Study Group. Multiple Micronutrient Supplementation during Pregnancy in Low-Income Countries:
Review of Methods and Characteristics of Studies Included in the Meta-Analyses. Food Nutr Bull. 2009;
30:S517–26. https://doi.org/10.1177/15648265090304S406 PMID: 20120793
13. Haider BA, Yakoob MY, Bhutta ZA. Effect of multiple micronutrient supplementation during pregnancy
on maternal and birth outcomes. BMC Public Health. 2011; 11:S19. https://doi.org/10.1186/1471-2458-
11-S3-S19 PMID: 21501436
14. Christian P, Osrin D, Manandhar DS, Khatry SK, de L Costello AM, West KP. Antenatal micronutrient
supplements in Nepal. Lancet. 2005; 366:711–2. https://doi.org/10.1016/S0140-6736(05)67166-8
PMID: 16125578
15. Devakumar D, Fall CHD, Sachdev HS, Margetts BM, Osmond C, Wells JCK, et al. Maternal antenatal
multiple micronutrient supplementation for long-term health benefits in children: a systematic review
and meta-analysis. BMC Medicine. 2016; 14:90. https://doi.org/10.1186/s12916-016-0633-3 PMID:
27306908
16. Persson LÅ, Arifeen S, Ekstro¨m E-C, Rasmussen KM, Frongillo EA, Yunus M, et al. Effects of Prenatal
Micronutrient and Early Food Supplementation on Maternal Hemoglobin, Birth Weight, and Infant Mor-
tality Among Children in Bangladesh: The MINIMat Randomized Trial. JAMA.2012; 307:2050–9.
https://doi.org/10.1001/jama.2012.4061 PMID: 22665104
17. Khan AI, Kabir I, Hawkesworth S, Ekstro¨m E-C, Arifeen S, Frongillo EA, et al. Early invitation to food
and/or multiple micronutrient supplementation in pregnancy does not affect body composition in off-
spring at 54 months: follow-up of the MINIMat randomised trial, Bangladesh. Matern Child Nutr. 2012;
11:385–97. https://doi.org/10.1111/mcn.12021 PMID: 23241449
18. Ekstro¨m E-C, Lindstro¨m E, Raqib R, Arifeen El S, Basu S, Brismar K, et al. Effects of prenatal micronu-
trient and early food supplementation on metabolic status of the offspring at 4.5 years of age. The MINI-
Mat randomized trial in rural Bangladesh. Int J Epidemiol. 2016; 45: 1656–1667. https://doi.org/10.
1093/ije/dyw199 PMID: 27694568
Cost-effectiveness of prenatal food and micronutrient interventions on under-five mortality and stunting
PLOS ONE | https://doi.org/10.1371/journal.pone.0191260 February 15, 2018 13 / 15
19. Shaheen R, Persson LÅ, Ahmed S, Streatfield PK, Lindholm L. Cost-effectiveness of invitation to food
supplementation early in pregnancy combined with multiple micronutrients on infant survival: analysis
of data from MINIMat randomized trial, Bangladesh. Ann Hum Biol. 2015; 15:1–8.
20. Mortality rate, under-5 (per 1,000 live births) | Data. In: data.worldbank.org [Internet]. [cited 30 Nov
2017]. Available: https://data.worldbank.org/indicator/SH.DYN.MORT
21. 2014 Nutrition Country Profile: Bangladesh. In: globalnutritionreport.org [Internet]. [cited 30 Nov 2017].
Available: http://www.globalnutritionreport.org/files/2014/11/gnr14_cp_bangladesh.pdf
22. Khan MM, Ahmed S. Relative efficiency of government and non-government organisations in imple-
menting a nutrition intervention programme–a case study from Bangladesh. Public Health Nutr. Cam-
bridge University Press; 2003; 6: 19–24. https://doi.org/10.1079/PHN2002359 PMID: 12581461
23. The World Bank. Consumer Price Index 1986–2015, Bangladesh. 2015. Available from: http://data.
worldbank.org/indicator/FP.CPI.TOTL?locations=BD Accessed 26 Feb 2017.
24. Shaheen R, Streatfield PK, Naved RT, Lindholm L, Persson LÅ. Equity in adherence to and effect of
prenatal food and micronutrient supplementation on child mortality: results from the MINIMat random-
ized trial, Bangladesh. BMC Public Health. 2014; 14:5. https://doi.org/10.1186/1471-2458-14-5 PMID:
24393610
25. World Health Organization. Global Burden of Disease 2004 update: Disability Weights for Diseases and
Conditions. Geneva: World Health Organization; 2004.
26. de Onis M, World Health Organization. WHO IRIS: WHO child growth standards: length/height-for-age,
weight-for-age, weight-for-length, weight -for-height and body mass index-for-age: methods and devel-
opment. 2006.
27. International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR B). Health and Demo-
graphic Surveillance System–Matlab. Registration of health and demographic events 2003. Dhaka:
Centre for Health and Population Research; 2005.
28. International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR B). Health and Demo-
graphic Surveillance System–Matlab. Registration of health and demographic events 2008. Dhaka:
Centre for Health and Population Research; 2010.
29. Svefors P, Rahman A, Ekstro¨m E-C, Khan AI, Lindstro¨m E, Persson LÅ, et al. Stunted at 10 Years. Lin-
ear Growth Trajectories and Stunting from Birth to Pre-Adolescence in a Rural Bangladeshi Cohort.
PLoS ONE. 2016; 11:e0149700–18. https://doi.org/10.1371/journal.pone.0149700 PMID: 26934484
30. Stein AD, Wang M, Martorell R, Norris SA, Adair LS, Bas I, et al. Growth patterns in early childhood and
final attained stature: Data from five birth cohorts from low- and middle-income countries. Am J Hum
Biol. 2009; 22:353–9.
31. Puett C, Sadler K, Alderman H, Coates J, Fiedler JL, Myatt M. Cost-effectiveness of the community-
based management of severe acute malnutrition by community health workers in southern Bangladesh.
Health Policy Plan. 2013; 28:386–99. https://doi.org/10.1093/heapol/czs070 PMID: 22879522
32. Borghi J, Thapa B, Osrin D, Jan S, Morrison J, Tamang S, et al. Economic assessment of a women’s
group intervention to improve birth outcomes in rural Nepal. Lancet. 2005; 366:1882–4. https://doi.org/
10.1016/S0140-6736(05)67758-6 PMID: 16310555
33. Menon P, McDonald CM, Chakrabarti S. Estimating the cost of delivering direct nutrition interventions
at scale: national and subnational level insights from India. Matern Child Nutr. 2016; 12:169–85. https://
doi.org/10.1111/mcn.12257 PMID: 27187914
34. LeFevre AE, Shillcutt SD, Waters HR, Haider S, Arifeen El S, Mannan I, et al. Economic evaluation of
neonatal care packages in a cluster-randomized controlled trial in Sylhet, Bangladesh. Bull World
Health Organ. 2013; 91:736–45. https://doi.org/10.2471/BLT.12.117127 PMID: 24115797
35. National Institute of Population Research and Training (NIPORT), Mitra and Associates, ICF Interna-
tional. Bangladesh Demographic and Health Survey 2011. NIPORT, Mitra and Associates, and ICF
International: Dhaka, Bangladesh, and Calverton USA; 2011.
36. Ziaei S, Rahman A, Raqib R, Lo¨nnerdal B, Ekstro¨m EC. A Prenatal Multiple Micronutrient Supplement
Produces Higher Maternal Vitamin B-12 Concentrations and Similar Folate, Ferritin, and Zinc Concen-
trations as the Standard 60-mg Iron Plus 400-g Folic Acid Supplement in Rural Bangladeshi Women. J
Nutr. 2016; 146:2520–2329. https://doi.org/10.3945/jn.116.235994 PMID: 27798335
37. Rahman S, Ahmed T, Rahman AS, Alam N, Ahmed AS, Ireen S, et al. Determinants of iron status and
Hb in the Bangladesh population: the role of groundwater iron. Public Health Nutr. 2016; 19:1862–74.
https://doi.org/10.1017/S1368980015003651 PMID: 26818180
38. Tiwari AKM, Mahdi AA, Chandyan S, Zahra F, Godbole MM, Jaiswar SP, et al. Oral iron supplementa-
tion leads to oxidative imbalance in anemic women: A prospective study. Clin Nutr ESPEN. 2011;
30:188–93.
Cost-effectiveness of prenatal food and micronutrient interventions on under-five mortality and stunting
PLOS ONE | https://doi.org/10.1371/journal.pone.0191260 February 15, 2018 14 / 15
39. Sazawal S, Black RE, Ramsan M, Chwaya HM, Stoltzfus RJ, Dutta A, et al. Effects of routine prophylac-
tic supplementation with iron and folic acid on admission to hospital and mortality in preschool children
in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Lancet.
2006; 367:133–43. https://doi.org/10.1016/S0140-6736(06)67962-2 PMID: 16413877
40. Haider BA, Bhutta ZA. Multiple-micronutrient supplementation for women during pregnancy. Cochrane
Database Syst Rev. 2015; 11:CD004905.
41. World Health Organization. WHO recommendations on antenatal care for a positive pregnancy experi-
ence. Geneva: World Health Organization; 2016.
42. Persson LÅ, Arifeen El S, Khan A, Rahman A, Ekstro¨m E-C. Effects of early prenatal food supplementa-
tion and multiple micronutrients on under-five survival, linear growth, metabolic markers and blood pres-
sure up to 10 years of age. The MINIMat trial in rural Bangladesh. The FASEB Journal. 2017; 31:
786.35–786.35.
43. O¨ zaltin E. Association of Maternal Stature With Offspring Mortality, Underweight, and Stunting in Low-
to Middle-Income Countries. JAMA. 2010; 303:1507–21. https://doi.org/10.1001/jama.2010.450 PMID:
20407060
44. Stein AD, Thompson AM, Waters A. Childhood growth and chronic disease: evidence from countries
undergoing the nutrition transition. Matern Child Nutr. 2005; 1:177–84. https://doi.org/10.1111/j.1740-
8709.2005.00021.x PMID: 16881898
45. Martorell R, Horta BL, Adair LS, Stein AD, Richter L, Fall CHD, et al. Weight gain in the first two years of
life is an important predictor of schooling outcomes in pooled analyses from five birth cohorts from low-
and middle-income countries. J. Nutr. 2010; 140:348–54. https://doi.org/10.3945/jn.109.112300 PMID:
20007336
Cost-effectiveness of prenatal food and micronutrient interventions on under-five mortality and stunting
PLOS ONE | https://doi.org/10.1371/journal.pone.0191260 February 15, 2018 15 / 15
